Company Stock Prices Before and After Public Announcements Related to Oncology Drugs von Rothenstein, Jeffrey M., Tomlinson, George, Tannock, Ian F., Detsky, Allan S.

Volltext

ALK inhibitors, resistance development, clinical trials von Rothenstein, J M, Chooback, N

Volltext

Managing treatment-related adverse events associated with Alk inhibitors von Rothenstein, J M, Letarte, N

Volltext

Non-malignant and tumor-derived cells differ in their requirement for p27Kip1 in transforming growth factor-beta-mediated G1 arrest von Donovan, Jeffrey C H, Rothenstein, Jeffrey M, Slingerland, Joyce M

Volltext

The Perceived Value of Liquid Biopsy: Results From a Canadian Validation Study of Circulating Tumor DNA T790M Testing—Patient’s Willingness-to-Pay: A Brief Report von Chen, Kaitlin H., Barnes, Tristan A., Laskin, Janessa, Cheema, Parneet, Liu, Geoffrey, Iqbal, Mussawar, Rothenstein, Jeffrey, Burkes, Ronald, Tsao, Ming-Sound, Leighl, Natasha B.

Volltext

Non-malignant and Tumor-derived Cells Differ in Their Requirement for p27Kip1 in Transforming Growth Factor-β-mediated G1 Arrest von Jeffrey C. H. Donovan, Jeffrey M. Rothenstein, Joyce M. Slingerland

Volltext

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC von Antonia, Scott J, Villegas, Augusto, Daniel, Davey, Vicente, David, Murakami, Shuji, Hui, Rina, Kurata, Takayasu, Chiappori, Alberto, Lee, Ki H, de Wit, Maike, Cho, Byoung C, Bourhaba, Maryam, Quantin, Xavier, Tokito, Takaaki, Mekhail, Tarek, Planchard, David, Kim, Young-Chul, Karapetis, Christos S, Hiret, Sandrine, Ostoros, Gyula, Kubota, Kaoru, Gray, Jhanelle E, Paz-Ares, Luis, de Castro Carpeño, Javier, Faivre-Finn, Corinne, Reck, Martin, Vansteenkiste, Johan, Spigel, David R, Wadsworth, Catherine, Melillo, Giovanni, Taboada, Maria, Dennis, Phillip A, Özgüroğlu, Mustafa

Volltext

Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer von Antonia, Scott J, Villegas, Augusto, Daniel, Davey, Vicente, David, Murakami, Shuji, Hui, Rina, Yokoi, Takashi, Chiappori, Alberto, Lee, Ki H, de Wit, Maike, Cho, Byoung C, Bourhaba, Maryam, Quantin, Xavier, Tokito, Takaaki, Mekhail, Tarek, Planchard, David, Kim, Young-Chul, Karapetis, Christos S, Hiret, Sandrine, Ostoros, Gyula, Kubota, Kaoru, Gray, Jhanelle E, Paz-Ares, Luis, de Castro Carpeño, Javier, Wadsworth, Catherine, Melillo, Giovanni, Jiang, Haiyi, Huang, Yifan, Dennis, Phillip A, Özgüroğlu, Mustafa

Volltext

Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1-Selected Advanced Non-Small-Cell Lung Cancer (BIRCH) von Peters, Solange, Gettinger, Scott, Johnson, Melissa L, Jänne, Pasi A, Garassino, Marina C, Christoph, Daniel, Toh, Chee Keong, Rizvi, Naiyer A, Chaft, Jamie E, Carcereny Costa, Enric, Patel, Jyoti D, Chow, Laura Q M, Koczywas, Marianna, Ho, Cheryl, Früh, Martin, van den Heuvel, Michel, Rothenstein, Jeffrey, Reck, Martin, Paz-Ares, Luis, Shepherd, Frances A, Kurata, Takayasu, Li, Zhengrong, Qiu, Jiaheng, Kowanetz, Marcin, Mocci, Simonetta, Shankar, Geetha, Sandler, Alan, Felip, Enriqueta

Volltext

Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program von Illini, Oliver, Hochmair, Maximilian Johannes, Fabikan, Hannah, Weinlinger, Christoph, Tufman, Amanda, Swalduz, Aurélie, Lamberg, Kristina, Hashemi, Sayed M. S., Huemer, Florian, Vikström, Anders, Wermke, Martin, Absenger, Gudrun, Addeo, Alfredo, Banerji, Shantanu, Calles, Antonio, Clarke, Stephen, Di Maio, Massimo, Durand, Alice, Duruisseaux, Michaël, Itchins, Malinda, Kääränien, Okko-Sakari, Krenn, Florian, Laack, Eckart, de Langen, Adrianus Johannes, Mohorcic, Katja, Pall, Georg, Passaro, Antonio, Prager, Gerald, Rittmeyer, Achim, Rothenstein, Jeffrey, Schumacher, Michael, Wöll, Ewald, Valipour, Arschang

Volltext

Selumetinib in patients receiving standard pemetrexed and platinum-based chemotherapy for advanced or metastatic KRAS wildtype or unknown non-squamous non-small cell lung cancer: A... von Melosky, Barbara, Bradbury, Penelope, Tu, Dongsheng, Florescu, Marie, Reiman, Anthony, Nicholas, Garth, Basappa, Naveen, Rothenstein, Jeffrey, Goffin, John R., Laurie, Scott A., Wheatley-Price, Paul, Leighl, Natasha, Goss, Glenwood, Reaume, M. Neil, Butts, Charles, Murray, Nevin, Card, Cynthia, Ko, Jenny, Blais, Normand, Gray, Samantha, Lui, Hongbo, Brown-Walker, Pamela, Kaurah, Pardeep, Prentice, Leah M., Seymour, Lesley

Volltext

Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN) : a retrospective analysis of patients treated through an access program von Illini, Oliver, Hochmair, Maximilian Johannes, Fabikan, Hannah, Weinlinger, Christoph, Tufman, Amanda, Swalduz, Aurelie, Lamberg, Kristina, Hashemi, Sayed M. S, Huemer, Florian, Vikström, Anders, Wermke, Martin, Absenger, Gudrun, Addeo, Alfredo, Banerji, Shantanu, Calles, Antonio, Clarke, Stephen, Di Maio, Massimo, Durand, Alice, Duruisseaux, Michael, Itchins, Malinda, Kääränien, Okko-Sakari, Krenn, Florian, Laack, Eckart, de Langen, Adrianus Johannes, Mohorcic, Katja, Pall, Georg, Passaro, Antonio, Prager, Gerald, Rittmeyer, Achim, Rothenstein, Jeffrey, Schumacher, Michael, Woell, Ewald, Valipour, Arschang

Volltext bestellen